Aurora Cannabis Inc
NASDAQ:ACB
Intrinsic Value
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. [ Read More ]
The intrinsic value of one ACB stock under the Base Case scenario is 4.19 USD. Compared to the current market price of 6.66 USD, Aurora Cannabis Inc is Overvalued by 37%.
Valuation Backtest
Aurora Cannabis Inc
Run backtest to discover the historical profit from buying and selling ACB stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Aurora Cannabis Inc
Current Assets | 406.5m |
Cash & Short-Term Investments | 148.6m |
Receivables | 43.3m |
Other Current Assets | 214.7m |
Non-Current Assets | 410.6m |
PP&E | 295.6m |
Intangibles | 79.1m |
Other Non-Current Assets | 35.9m |
Current Liabilities | 107.4m |
Accounts Payable | 22.7m |
Accrued Liabilities | 38.6m |
Other Current Liabilities | 46.1m |
Non-Current Liabilities | 193.3m |
Long-Term Debt | 78.4m |
Other Non-Current Liabilities | 115m |
Earnings Waterfall
Aurora Cannabis Inc
Revenue
|
267m
CAD
|
Cost of Revenue
|
-261.8m
CAD
|
Gross Profit
|
5.2m
CAD
|
Operating Expenses
|
-178.6m
CAD
|
Operating Income
|
-173.5m
CAD
|
Other Expenses
|
39.5m
CAD
|
Net Income
|
-133.9m
CAD
|
Free Cash Flow Analysis
Aurora Cannabis Inc
ACB Profitability Score
Profitability Due Diligence
Aurora Cannabis Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
Score
Aurora Cannabis Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
ACB Solvency Score
Solvency Due Diligence
Aurora Cannabis Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Score
Aurora Cannabis Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ACB Price Targets Summary
Aurora Cannabis Inc
According to Wall Street analysts, the average 1-year price target for ACB is 5.82 USD with a low forecast of 3.65 USD and a high forecast of 9.58 USD.
Shareholder Return
ACB Price
Aurora Cannabis Inc
Average Annual Return | -65.29% |
Standard Deviation of Annual Returns | 19.59% |
Max Drawdown | -100% |
Market Capitalization | 143.9m CAD |
Shares Outstanding | 15 726 900 |
Percentage of Shares Shorted | 3.1% |
ACB News
Last Important Events
Aurora Cannabis Inc
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Aurora Cannabis Inc
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. The firm's principal business lines are focused on the production, distribution and sale of cannabis and cannabis related products in Canada and internationally. The firm's portfolio of brands includes Aurora, Aurora Drift, San Rafael '71, Daily Special, MedReleaf, CanniMed, Whistler, Reliva and KG7 CBD. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia; and Odense, Denmark. The firm is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets. The company produces approximately 150,000 kilograms (kg) of cannabis biomass annually. Its subsidiaries include 1769474 Alberta Ltd., 2105657 Alberta Inc., Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Aurora Nordic Cannabis A/S, and Reliva, LLC, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one ACB stock under the Base Case scenario is 4.19 USD.
Compared to the current market price of 6.66 USD, Aurora Cannabis Inc is Overvalued by 37%.